CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Low Molecular Weight HeparinWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D019851 Thrombophilia NIH 0.58

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0100724 Hypercoagulability HPO 0.58

There is one clinical trial.

Clinical Trials

1 Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto

The HETHICO study aims to collect retrospectively documented clinical information on patients hospitalized in Veneto Region (Italy) for SARS-COVID-2 infection in 2 types of settings, medical environment (COORTE MED), and intensive / sub-intensive (COORTE ICU), to assess the safety and possible efficacy of the anticoagulant treatments used for thromboprophylaxis, or in preventing thrombotic complications related to hospitalization from COVID-19.

NCT04393805 COVID-19 Hypercoagulability Drug: Low Molecular Weight Heparin
MeSH:Thrombophilia
HPO:Hypercoagulability

Primary Outcomes

Description: Collect and evaluate in real-life the safety data of the anti-coagulant treatments used by estimating the incidence of bleeding complications during hospitalization.

Measure: Bleeding

Time: 28 days

Description: Collect and evaluate in real-life the efficacy data of the anti-coagulant treatments used by estimating the incidence of deep vein thrombosis and/or pulmonary embolism during hospitalization.

Measure: Thrombosis

Time: 28 days

Description: Collect and evaluate in real-life the data by estimating incidence of intra-hospital death.

Measure: Mortality

Time: 28 days

Secondary Outcomes

Description: clinical worsening with transfer to the intensive/sub-intensive ward

Measure: Worsening

Time: 28 days

Description: length of stay

Measure: LOS

Time: 60 days

Related HPO nodes (Using clinical trials)

HP:0100724: Hypercoagulability
Genes 20
SLC4A1 SPTA1 F9 DLD AGGF1 MYD88 SPTB ANK1 PROS1 PLAT PROC EPB42 PROC GATA2 THBD F5 HBB PIGA HRG PROS1
Protein Mutations 2
G20210A V617F
SNP 2
rs1799963 rs6025